2006
DOI: 10.1590/s0103-507x2006000400008
|View full text |Cite
|
Sign up to set email alerts
|

Metanálise sobre o uso de glicocorticóides pré-operatório para redução do risco de complicações após esofagectomia por carcinoma do esôfago

Abstract: RESUMO JUSTIFICATIVA E OBJETIVOS: O emprego de glicocorticóides tem sido proposto para reduzir a morbidade após intervenções cirúrgicas, porém, não é largamente utilizado antes da ressecção do esôfago porque não existem conhecimentos suficientes sobre a sua eficácia. O objetivo do trabalho foi verificar os efeitos da administração pré-operatória de glicocorticóides, em pacientes submetidos à esofagectomia por carcinoma de esôfago. RESULTADOS: Quatro estudos envolvendo 169 pacientes foram localizados. Não ocorr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2010
2010
2012
2012

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 9 publications
(10 reference statements)
0
4
0
Order By: Relevance
“…Crosssectional studies and case reports were the most frequent design type in both journals, representing over 50% of all the clinical articles published during that year. Out of the 289 articles published in 2007, four were randomized (or quasi-randomized) trials [9][10][11][12] and four were systematic reviews, [13][14][15][16] thus representing less than 2% of the total number of published papers in both of these journals. After exclusion of six clinical guidelines [17][18][19][20][21][22] and 80 non-evidence articles (technical notes, clinical measurement validation studies, continuing medical education, quizzes and others) the distribution of the remaining 203 articles is presented in Table 2.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Crosssectional studies and case reports were the most frequent design type in both journals, representing over 50% of all the clinical articles published during that year. Out of the 289 articles published in 2007, four were randomized (or quasi-randomized) trials [9][10][11][12] and four were systematic reviews, [13][14][15][16] thus representing less than 2% of the total number of published papers in both of these journals. After exclusion of six clinical guidelines [17][18][19][20][21][22] and 80 non-evidence articles (technical notes, clinical measurement validation studies, continuing medical education, quizzes and others) the distribution of the remaining 203 articles is presented in Table 2.…”
Section: Resultsmentioning
confidence: 99%
“…According to the Oxford criteria, 25.6% of the articles were classified as level 4 or 5 evidence, while 2.8% were level 1. Table 3 presents the AMSTAR scores of the four systematic reviews [13][14][15][16] published during 2007 in the two journals. The overall scores ranged from 1 to 6, with a mean score of 4.0 (standard deviation: 2.2).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, there were studies that only focused on the prevalence or incidence of health problem events (I) (12)(13)27,32,45,(47)(48)67,81,(83)(84)(85)(86)90,92) ; others to iden fy and/or associate risk factors (II) ( ; and s ll others to correlate interven ons with preven on, prophylaxis or reduc on of events (III) (14)(15)(17)(18)20,23,33,46,(50)(51)(53)(54)(55)58,62,(64)(65)(68)(69)(70)(71)(72)(73)(74)(75)(76)(79)(80)82,89,91,(93)(94) .…”
Section: Discussionmentioning
confidence: 99%